1. Home
  2. Browse
  3. Diabetes & Endocrinology
  4. Resources

Resources

181 - 195 of 268 Results
Sort Results:
Article: ACE inhibitor or ARB to prevent kidney disease April 2012
PL Voices: New Once WEEKLY Exenatide (Bydureon) March 2012
Article: Bydureon (by-DUR-ee-on), a new long-acting form of Byetta (exenatide) for type 2 diabetes March 2012
Commentary: Actos (Pioglitazone) and Increased Risk of Bladder Cancer July 2011
Guideline: Evidence-based Guideline: Treatment of Painful Diabetic Neuropathy (2011) June 2011
Chart: Comparison of Common Meds for Diabetic Neuropathy June 2011
Commentary: New Drug: Tradjenta (Linagliptin) June 2011
Guideline: Medical Management of Hyperglycemia in Type 2 Diabetes: A Consensus Algorithm for the Initiation and Adjustment of Therapy (2009) June 2011
Patient Education: Blood Pressure Medications and You February 2011
Commentary: Cycloset: A New Bromocriptine Formulation for Diabetes February 2011
Chart: Stepwise Approach to Selecting Treatments for Type 2 Diabetes (AACE) October 2010
Commentary: Restricted Use of Rosiglitazone-Containing Products October 2010
Commentary: Actos (Pioglitazone) and Risk of Bladder Cancer October 2010
Guideline: Consensus Statement on Management of Hyperglycemia in Type 2 Diabetes (ADA, 2009) August 2010
Other: See new FDA information concerning the restricted use of Avandia August 2010